Pathological Advances and Clinical Management Insights into Primary Pulmonary Myxoid Sarcoma Harboring the Rare EWSR1 :: CREB1 Fusion.

Int J Surg PatholJun 10, 2026 (epub)

Yifei Liu, Yuying Sun, Qing Zhang

✦ AI-curated · Sources linked

Case in brief

A 64-year-old woman had a primary pulmonary myxoid sarcoma that had been present for 7 years without symptoms. The tumor was resected, and fluorescence in situ hybridization confirmed an EWSR1::CREB1 fusion, supporting the pathological diagnosis. She received no adjuvant therapy and had no evidence of disease 46 months after surgery.

What made this case unusual

The tumor’s prolonged, asymptomatic presence before resection and absence of disease at follow-up after surgery document an indolent course in this patient.

Diagnostic / clinical pearl

In a suspected primary pulmonary myxoid sarcoma, confirmation of the EWSR1::CREB1 fusion by fluorescence in situ hybridization can support the pathological diagnosis.

Source

Published in Int J Surg Pathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.